http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1181069-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c4cb9b5558ad97d3acc0db1113f7727
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-08
filingDate 1981-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1985-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a33403de2826f0332961c92539fc5847
publicationDate 1985-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1181069-A
titleOfInvention Process for preparing 1-(trialkoxybenzyl) piperazines
abstract SPECIFIC The invention relates to the preparation of (trialcoxy benzyl) -1 piperazines and in particular of (2,3,4,4-trimethoxy benzyl) -1 piperazine. the process consists in preparing, in a first phase, the piperazinone-2 corresponding to said piperazine, then to reduce, in a second phase, said piperazinone. More specifically, in the first phase, a mole is reacted in a first solvent of a trialkoxy benzyl chloride on two moles of piperazinone-2 to obtain a trialcoxy benzyl-4 piperazinone-2 and, in the second phase, we reduce this last compound, in a second solvent, using a hydride. preferably the first solvent is toluene, the second solvent tetrahydrofuran and said hydride AlLiH4 or B2H6. (no drawing)
priorityDate 1980-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420313929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421334983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID231360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415801062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97491

Total number of triples: 34.